(Press-News.org) New consensus statements have been developed to help tackle the growing threat of multidrug-resistant tuberculosis (TB) and extensively drug-resistant tuberculosis (TB).
Published online today (24 March 2014) in the European Respiratory Journal¸ the statements mark the first time that physicians who treat patients with multidrug- and extensively drug-resistant TB have reached a consensus on important areas of patient management where scientific evidence is inconclusive.
The World Health Organization (WHO) estimates that currently 450,000 new cases with MDR-TB occur each year. The majority of affected patients live in the WHO European Region.
As the emergence of these forms of the disease is fairly recent, clinical evidence is lacking and could be for many years to come. To help bridge this gap in knowledge, experts from the European-based TBNET network have provided harmonised answers to the key questions for the prevention, diagnosis, treatment and management of multidrug- and extensively drug-resistant TB.
Although some guidelines are available for the treatment of people with multidrug- and extensively drug-resistant TB, this is the first time that a large group of predominantly clinical experts have joined together to provide a consensus on the management of these conditions in Europe.
The consensus statements also include useful checklists with information on which examinations should be performed during the course of the treatment and what is necessary before discharging a patient from the hospital. The authors suggest that the document can be used as a point of reference for physicians across the continent.
Lead author, Professor Christoph Lange, Head of the Respiratory Infections Assembly at the European Respiratory Society, said: "These consensus statements provide very valuable support for physicians treating patients with these deadly conditions in all parts of Europe. The current management of patients with multidrug- and extensively drug-resistant TB is complex, very costly for healthcare systems and burdensome for those who are affected.
"We have harmonised individual expert opinions on the management of multidrug- and extensively drug-resistant TB in adults and children to ensure that consensus is available where clinical evidence is still lacking. As clinicians we hope to improve the treatment of multidrug- and extensively drug-resistant TB and the life of our patients who suffer from these difficult-to-treat conditions."
INFORMATION:
Title: Management of patients with multidrug-resistant and extensively drug-resistant TB in Europe: TBNET consensus statement.
Authors: Christoph Lange, Ibrahim Abubakar, Jan-Willem C. Alffenaar, Graham Bothamley, Jose A. Caminero, Anna Cristina C. Carvalho, Kwok-Chiu Chang, Luigi Codecasa, Ana Correia, Valeriu Crudu, Peter Davies, Martin Dedicoat, Francis Drobniewski, Raquel Duarte, Cordula Ehlers, Connie Erkens, Delia Goletti, Gunar Günther, Elmira Ibraim, Beate Kampmann, Liga Kuksa, Wiel de Lange, Frank van Leth, Jan van Lunzen, Alberto Matteelli, Dick Menzies, Ignacio Monedero, Elvira Richter, Sabine Rüsch-Gerdes, Andreas Sandgren, Anna Scardigli, Alena Skrahina, Enrico Tortoli, Grigory Volchenkov, Dirk Wagner, Marieke J. van der Werf, Bhanu Williams, Wing-Wai Yew, Jean Pierre Zellweger and Daniela Maria Cirillo for the TBNET
DOI: 10.1183/09031936.00188313
New consensus reached to help tackle multidrug-resistant and extensively drug-resistant TB
2014-03-24
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
The Lancet journals: World TB Day media alert
2014-03-24
To mark the Stop TB Partnerships' World TB Day on Monday 24 March 2014, The Lancet journals will publish a special new collection of Reviews, Comment, and Articles to cast light, and the world's attention, on tuberculosis, in the hope of raising this disease higher up the agendas of international communities.
The new publications discuss topics ranging from extremely drug-resistant tuberculosis, to the role of advocacy in tuberculosis, and new anti-tuberculosis drugs, highlighting the key areas and challenges to be met if inroads are to be made into winning the battle ...
New childhood tuberculosis estimates double the number previously thought
2014-03-24
Researchers from Brigham and Women's Hospital (BWH) and Harvard Medical School (HMS) in Boston have estimated that around one million children suffer from tuberculosis (TB) annually— twice the number previously thought to have tuberculosis and three times the number that are diagnosed every year. The researchers also estimated that around 32,000 children suffer from multidrug-resistant tuberculosis (MDR-TB) annually. These findings are published in The Lancet on March 23, 2014.
"Despite children comprising approximately one quarter of the world's population, there ...
Mass. General study identifies path to safer drugs for heart disease, cancer
2014-03-23
Massachusetts General Hospital (MGH) investigators may have found a way to solve a problem that has plagued a group of drugs called ligand-mimicking integrin inhibitors, which have the potential to treat conditions ranging from heart attacks to cancer metastasis. In a Nature Structural & Molecular Biology paper receiving advance online publication, the researchers provide a structural basis for the design of new and safer integrin inhibitors.
Integrins are receptor proteins found on the surface of cells that determine whether or not cells adhere to adjacent cells and ...
Unavoidable disorder used to build nanolaser
2014-03-23
Researchers the world round are working to develop optical chips, where light can be controlled with nanostructures. These could be used for future circuits based on light (photons) instead of electron - that is photonics instead of electronics. But it has proved to be impossible to achieve perfect photonic nanostructures: they are inevitably a little bit imperfect. Now researchers at the Niels Bohr Institute in collaboration with DTU have discovered that imperfect nanostructures can offer entirely new functionalities. They have shown that imperfect optical chips can be ...
Could diamonds be a computer's best friend?
2014-03-23
COLUMBUS, Ohio—For the first time, physicists have demonstrated that information can flow through a diamond wire.
In the experiment, electrons did not flow through diamond as they do in traditional electronics; rather, they stayed in place and passed along a magnetic effect called "spin" to each other down the wire—like a row of sports spectators doing "the wave."
Spin could one day be used to transmit data in computer circuits—and this new experiment, done at The Ohio State University, revealed that diamond transmits spin better than most metals in which researchers ...
Leukaemia caused by chromosome catastrophe
2014-03-23
Researchers have found that people born with a rare abnormality of their chromosomes have a 2,700-fold increased risk of a rare childhood leukaemia. In this abnormality, two specific chromosomes are fused together but become prone to catastrophic shattering.
Acute lymphoblastic leukaemia, or ALL, is the most common childhood cancer. Scientists previously found that a small subset of ALL patients have repeated sections of chromosome 21 in the genomes of their leukaemia cells. This form of ALL – iAMP21 ALL – requires more intensive treatment than many other types of ALL. ...
Drugs fail to reawaken dormant HIV infection
2014-03-23
Scientists at Johns Hopkins report that compounds they hoped would "wake up" dormant reservoirs of HIV inside immune system T cells — a strategy designed to reverse latency and make the cells vulnerable to destruction — have failed to do so in laboratory tests of such white blood cells taken directly from patients infected with HIV.
"Despite our high hopes, none of the compounds we tested in HIV-infected cells taken directly from patients activated the latent virus," says Robert F. Siliciano, M.D., Ph.D., a professor of medicine at the Johns Hopkins University School ...
MIT engineers design 'living materials'
2014-03-23
CAMBRIDGE, MA -- Inspired by natural materials such as bone — a matrix of minerals and other substances, including living cells — MIT engineers have coaxed bacterial cells to produce biofilms that can incorporate nonliving materials, such as gold nanoparticles and quantum dots.
These "living materials" combine the advantages of live cells, which respond to their environment, produce complex biological molecules, and span multiple length scales, with the benefits of nonliving materials, which add functions such as conducting electricity or emitting light.
The new materials ...
Off-rift volcanoes explained
2014-03-23
Potsdam: Rift valleys are large depressions formed by tectonic stretching forces. Volcanoes often occur in rift valleys, within the rift itself or on the rift flanks as e.g. in East Africa. The magma responsible for this volcanism is formed in the upper mantle and ponds at the boundary between crust and mantle. For many years, the question of why volcanoes develop outside the rift zone in an apparently unexpected location offset by tens of kilometers from the source of molten magma directly beneath the rift has remained unanswered. A team of scientists from the GFZ German ...
Southeast England most at risk of rising deaths due to climate change
2014-03-23
Warmer summers brought on by climate change will cause more deaths in London and southeast England than the rest of the country, scientists predict.
Researchers at Imperial College London looked at temperature records and mortality figures for 2001 to 2010 to find out which districts in England and Wales experience the biggest effects from warm temperatures.
In the most vulnerable districts, in London and the southeast, the odds of dying from cardiovascular or respiratory causes increased by over 10 per cent for every 1C rise in temperature. Districts in the far north ...